Insurtech Market Size to Hit $275.72 Billion by 2035 | SNS Insider

The U.S. insurtech market is projected to reach $91.60B by 2035 and Europe $72.43B, supported by AI-powered claims processing, digital underwriting, fraud prevention, and increased cloud adoption. Growth is further bolstered by rising demand for personalized insurance products.

Analysis

The economic winner is likely not the branded insurtech stack but the incumbents that already own distribution, balance sheet, and claims data. AI in this market is mostly a margin story: lower expense ratios, faster claims settlement, and tighter fraud screening should improve combined ratios for large carriers before it meaningfully expands the overall addressable premium pool.

That creates a second-order squeeze on standalone insurtechs. If automation makes underwriting and claims cheaper, the advantage migrates to firms that can amortize the tools across a large book, forcing smaller players to compete more aggressively on price and CAC rather than technology differentiation. Over 1-3 quarters, the market may reward any carrier that shows measurable operating leverage; over 6-18 months, the bigger risk is that savings get competed away into lower premiums, limiting upside for pure-play software monetization.

The main contrarian point is that this may be more of a procurement cycle than a new growth regime. A lot of the projected value can be captured by legacy core systems, cloud infrastructure, and large P&C/health carriers rather than by venture-style insurtech names. The trade only becomes durable if we see hard evidence of loss-ratio improvement or expense-ratio compression on earnings calls; absent that, the headline TAM should be treated as long-dated and partially already embedded in valuation assumptions for the public names most exposed to AI automation.

Key Decisions for Investors

• Long PGR or CB vs short LMND/ROOT over 6-12 months: best risk/reward is a relative-value trade on operating leverage, with incumbents more likely to convert AI into EPS while pure plays face pricing pressure. Falsifier: evidence that LMND/ROOT can expand policies without rising CAC or worsening loss ratios.
• Buy HIG/TRV on pullbacks into earnings, 1-3 quarters: the setup is for incremental combined-ratio improvement if claims automation is real. Upside is modest but cleaner than chasing headline insurtech beta; cut if management does not quantify expense savings by next print.
• Avoid chasing broad insurtech exposure until a carrier discloses measurable workflow savings; treat recent strength in high-burn names as sellable into rallies via put spreads if they rerate on TAM optimism without KPI improvement.
• Watch MSFT and AMZN as indirect winners from cloud migration in regulated insurance workflows; initiate only if insurer commentary shows accelerating modernization budgets, because this is a slow burn rather than a near-term catalyst.